Cardiovascular Disease Flashcards
Lotensin
Benazepril (PO)
Pharmacologic category: angiotensin-converting enzyme (ACE) inhibitor
Common indication: HTN, chronic HF, CAD
Key side effects: cough, hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Vasotec
Enalapril (PO)
Pharmacologic category: angiotensin-converting enzyme (ACE) inhibitor
Common indication: HTN, chronic HF, CAD
Key side effects: cough, hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Prinivil, Zestril
Lisinopril (PO)
Pharmacologic category: angiotensin-converting enzyme (ACE) inhibitor
Common indication: HTN, chronic HF, CAD
Key side effects: cough, hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Accupril
Quinapril (PO)
Pharmacologic category: angiotensin-converting enzyme (ACE) inhibitor
Common indication: HTN, chronic HF, CAD
Key Side effects: cough, hyperkalemia, angioedema
US Boxed warnings: fetal toxicity (CI in pregnancy)
Altace
Ramipril (PO)
Pharmacologic category: angiotensin-converting enzyme (ACE) inhibitor
Common indication: HTN, chronic HF, CAD
Key side effects: cough, hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Avapro
Irbesartan (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB)
Common indication: HTN, CAD
Key side effects: hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Cozaar
Losartan (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB)
Common indication: HTN, CAD
Key side effects: hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Benicar
Olmesartan (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB)
Common indication: HTN, CAD
Key side effects: hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Micardis
Telmisartan (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB)
Common indication: HTN, CAD
Key side effects: hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Diovan
Valsartan (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB)
Common indication: HTN, chronic HF, CAD
Key side effects: hyperkalemia, angioedema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Norvasc
Amlodipine (PO)
Pharmacologic category: dihydropyridine calcium channel blocker (CCB)
Common indication: HTN, CAD
Key side effects: edema
Other Notes: not all generic products therapeutically equivalent
Procardia XL, Nifedical XL, Adalat CC
Nifedipine (PO)
Pharmacologic category: dihydropyridine calcium channel blocker
Common indication: HTN, CAD
Key side effects: edema
Other Notes: not all generic products therapeutically equivalent
Cardene
Nicardipine (PO, IV)
Pharmacologic category: dihydropyridine calcium channel blocker (CCB)
Common indication: hypertensive crisis
Key side effects: flushing, headache, edema, hypotension
Cartia XT, Cardizem, Cardizem CD, Cardizem LA
Diltiazem (PO, IV)
Pharmacologic category: non-dihydropyridine calcium channel blocker (CCB)
Common indication: AF (rate control), HTN, CAD
Key side effects: bradycardia, peripheral edema, constipation
Calan, Calan SR, Verelan
Verapamil (PO)
Pharmacologic category: non-dihydropyridine calcium channel blocker (CCB)
Common indication: AF (rate control), HTN, CAD
Key side effects: bradycardia, peripheral edema, constipation
Microzide
Hydrochlorothiazide (PO)
Pharmacologic category: thiazide diuretic
Common indication: HTN, volume overload
Key side effects: hypokalemia, hyponatremia
Thalitone
Chlorthalidone (PO)
Pharmacologic category: thiazide-related diuretic
Common indication: HTN, volume overload
Key side effects: hypokalemia, hyponatremia
Zaroxolyn
Metolazone (PO)
Pharmacologic category: thiazide-related diuretic
Common indication: HTN, volume overload
Key side effects: hypokalemia, hyponatremia
Lotrel
Amlodipine and benazepril (PO)
Pharmacologic category: dihydropyridine calcium channel blocker and angiotensin-converting enzyme (ACE) inhibitor
Common indication: HTN, chronic HF, CAD
Key side effects: cough, hyperkalemia, angioedema, edema
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Prinzide
Lisinopril and hydrochlorothiazide (PO)
Pharmacologic category: angiotensin-converting enzyme (ACE) inhibitor and thiazide diuretic
Common indication: HTN, chronic HF, CAD, volume overload
Key side effects: cough, hyperkalemia, angioedema, hypokalemia, hyponatremia
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Hyzaar
Losartan and hydrochlorothiazide (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB) and thiazide diuretic
Common indication: HTN, CAD, volume overload
Key side effects: hyperkalemia, angioedema, hypokalemia, hyponatremia
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Benicar-HCT
Olmesartan and hydrochlorothiazide (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB) and thiazide diuretic
Common indication: HTN, CAD, volume overload
Key side effects: hyperkalemia, angioedema, hypokalemia, hyponatremia
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Micardis-HCT
Telmisartan and hydrochlorothiazide (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB) and thiazide diuretic
Common indication: HTN, CAD, volume overload
Key side effects: hyperkalemia, angioedema, hypokalemia, hyponatremia
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Dyazide, Maxzide
Triamterene and hydrochlorothiaizde (PO)
Pharmacologic category: potassium-sparing diuretic and thiazide diuretic
Common indication: HTN, volume overload
Key side effects: hypokalemia, hyponatremia
Diovan-HCT
Valsartan and hydrochlorothiazide (PO)
Pharmacologic category: angiotensin II receptor blocker (ARB) and thiazide diuretic
Common indication: HTN, chronic HF, CAD, volume overload
Key side effects: hyperkalemia, angioedema, hypokalemia, hyponatremia
US Boxed Warnings: fetal toxicity (CI in pregnancy)
Aldactone
spironolactone (PO)
Pharmacologic category: potassium-sparing diuretic
Common indication: HTN, chronic HF, ascites
Key side effects: gynecomastia, hyperkalemia
US Boxed Warnings: tumorigenic
Bumex
Bumetanide (PO, IV)
Pharmacologic category: Loop diuretic
Common indication: volume overload
Key side effects: hypokalemia, hypomagnesemia, hyponatremia
US Boxed Warnings: fluid and electrolyte loss
Lasix
Furosemide (PO, IV)
Pharmacologic category: Loop diuretic
Common indication: volume overload
Key side effects: hypokalemia, hypomagnesemia, hyponatremia
US Boxed Warnings: fluid and electrolyte loss
Demadex
Torsemide (PO)
Pharmacologic category: loop diuretic
Common indication: volume overload
Key side effects: hypokalemia, hypomagnesemia, hyponatremia
US Boxed Warnings: fluid and electrolyte loss
Tenormin
Atenolol (PO)
Pharmacologic category: beta1-selective beta-blocker
Common indication: AF (rate control), CAD, HTN
Key side effects: bradycardia
US Boxed Warnings: avoid abrupt discontinuation
Other Notes: masks symptoms of hypoglycemia
Lopressor
Metoprolol tartrate (PO, IV)
Pharmacologic category: beta1-selective beta-blocker
Common indication: AF (rate control), CAD, HTN
Key side effects: bradycardia
US Boxed Warnings: avoid abrupt discontinuation
Other Notes: masks symptoms of hypoglycemia
Toprol-XL
Metoprolol succinate (PO)
Pharmacologic category: beta1-selective beta-blocker
Common indication: chronic HF, AF (rate control), CAD, HTN
Key side effects: bradycardia
Other Notes: masks symptoms of hypoglycemia
Bystolic
Nebivolol (PO)
Pharmacologic category: beta1-selective beta blocker
Common indication: HTN
Key side effects: bradycardia
Other Notes: masks symptoms of hypoglycemia
Coreg, Coreg CR
Carvedilol (PO)
Pharmacologic category: non-selective beta-blocker
Common indication: chronic HF, AF (rate control), CAD, HTN
Key side effects: bradycardia
Other Notes: ISMP-high alert medication; masked symptoms of hypoglycemia
Trandate
Labetalol (PO, IV)
Pharmacologic category: non-selective beta-blocker
Common indication: PO: HTN; IV: hypertensive crisis
Key side effects: Bradycardia
Other Notes: ISMP-high alert medication; masks symptoms of hypoglycemia
Inderal LA, Inderal XL
Propranolol (PO)
Pharmacologic category: non-selective beta-blocker
Common indication: HTN, CAD
Key side effects: bradycardia
US Boxed Warnings: avoid abrupt discontinuation
Other Notes: masks symptoms of hypoglycemia
PO: Catapres; Transdermal: Catapress-TTS
Clonidine (PO, transdermal)
Pharmacologic category: alpha2 agonist
Common indication: HTN, ADHD
Key side effects: xerostomia, drowsiness
US Boxed Warnings: avoid epidural use
Other Notes: do not discontinue abruptly; taper to reduce rebound HTN
Apresoline
Hydralazine (PO, IV)
Pharmacologic category: direct arterial vasodilator
Common indication: HTN
Key side effects: orthostatic hypotension, drug-induced lupus-like syndrome
Dobutamine (IV)
Pharmacologic category: beta1 and beta2 agonist; inotrope
Common indication: ADHF, cardiogenic shock
Key side effects: tachyarrhythmias
Other Notes: ISMP-high alert medication
Adrenalin
Epinephrine (IV, IM, subcutaneous)
Pharmacologic category: beta1, beta2, and alpha1 agonist
Common indication: advanced cardiac life support, shock, anaphylaxis, bradycardia
Key side effects: tachyarrhythmias, peripheral ischemia, lactic acidosis
Other Notes: ISMP-high alert medication
Levophed
Norepinephrine (IV)
Pharmacologic category: alpha1 agonist (predominantly), beta1 and beta2 agonist
Common indication: shock
Key side effects: tachyarrhythmias, peripheral ischemia
US Boxed Warning: extravasation (central line administration preferred)
Other Notes: ISMP-high alert medication
Ziac
Bisoprolol and hydrochlorothiazide (PO)
Pharmacologic category: beta1 selective beta blocker and thiazide diuretic
Common indication: HTN
Key side effects: upper respiratory infection, fatigue, rhinitis, arthralgia, hypokalemia, hyponatremia
Pradaxa
Dabigatran (PO)
Pharmacologic category: anticoagulant, direct thrombin inhibitor
Common indication: AF (stroke prevention), VTE
Key side effects: bleeding, dyspepsia
US Boxed Warnings: premature discontinuation increases risk of thrombotic events
Other Notes: ISMP-high alert medication; swallow whole; dispense and store in original packaging; discard 4 months after opening
Eliquis
Apixaban (PO)
Pharmacologic category: anticoagulant, factor Xa inhibitor
Common indication: AF (stroke prevention), VTE
Key side effects: bleeding
US Boxed Warnings: premature discontinuation increases risk of thrombotic events
Other Notes: ISMP-high alert medication
Xarelto
Rivaroxaban (PO)
Pharmacologic category: anticoagulant, factor Xa inhibitor
Common indication: AF (stroke prevention), VTE
Key side effects: bleeding
US Boxed Warnings: premature discontinuation increases risk of thrombotic events
Other Notes: ISMP-high alert medication
Coumadin, Jantoven
warfarin (PO)
Pharmacologic category: anticoagulant, vitamin K antagonist
Common indication: AF (stroke prevention), VTE
Key side effects: bleeding
US Boxed warnings: bleeding risk
Other Notes: narrow therapeutic index drugs (toxicity may occur at concentrations close to therapeutic range; therapeutic monitoring recommended with INR)
Other Notes: ISMP-high alert medication; dose dependent tablet colors; uniform vitamin K intake recommended; many drug interactions
Lovenox
Enoxaparin (subcutaneous)
Pharmacologic category: anticoagulant, low molecular weight heparin
Common indication: ACS, VTE
Key side effects: bleeding, hyperkalemia, HIT
US Boxed Warnings: increased risk of epidural or spinal hematoma in patient undergoing spinal puncture
Other Notes: ISMP-high alert medication; do not expel air bubble from syringe prior to injection
Heparin (IV, subcutaneous)
Pharmacologic category: anticoagulant
Common indication: ACS, VTE
Key side effects: bleeding, hyperkalemia, HIT
Other Notes: ISMP-high alert medication
Plavix
Clopidogrel (PO)
Pharmacologic category: antiplatelet agent
Common indication: CAD, stroke
Key side effects: bleeding
US Boxed Warnings: diminished effectiveness in poor metabolizers
Aggrenox
Aspirin and dipyridamole (PO)
Pharmacologic category: antiplatelet agent
Common indication: Stroke
Key side effects: bleeding, headache
Effient
Prasugrel (PO)
Pharmacologic category: antiplatelet agent
Common indication: CAD
Key side effects: bleeding
US Boxed Warnings: bleeding risk
Other Notes: CI in patients with history of stroke
Intracatheter: Cathflo; IV: Activase
Alteplase (intracatheter, IV)
Pharmacologic category: fibrinolytic
Common indication: Intracatheter: catheter clearance; IV: STEMI, ischemic stroke, PE
Key side effects: bleeding
Other Notes: ISMP-high alert medication, CI in patients with severe uncontrolled HTN
Cordarone, Pacerone
Amiodarone (PO, IV)
Pharmacologic category: Antiarrhythmic
Common indication: AF, ventricular fibrillation, ventricular tachycardia
Key side effects: hypothyroidism, hyperthyroidism, pulmonary toxicity, hepatotoxicity
US Boxed Warnings: life-threatening arrhythmias, pulmonary toxicity, hepatotoxicity
Other Notes: ISMP-high alert medication; many drug interactions
Betapace
sotalol (PO, IV)
Pharmacologic category: antiarrhythmic
Common indication: AF (rhythm control)
Key side effects: bradycardia, arrhythmias
US Boxed Warnings: life-threatening proarrhythmia
Imdur
Isosorbide mononitrate (PO)
Pharmacologic category: vasodilator
Common indication: CAD
Key side effects: headache
Nitrostat, NitroQuick
Nitroglyercin (PO, IV)
Pharmacologic category: vasodilator
Common indication: CAD
Key side effects: headache
Welchol
Colesevelam (PO)
Pharmacologic category: bile acid sequestrant
Common indication: dyslipidemia
Key side effects: constipation, dyspepsia
Digitek, Digox, Lanoxin
Digoxin (PO, IV)
Pharmacologic category: cardiac glycoside
Common indication: AF (rate control), chronic HF
Key side effects: nausea, vomiting, visual changes
Other Notes: ISMP-high alert medication, narrow therapeutic index drug (toxicity may occur at concentrations close to therapeutic range; therapeutic drug monitoring is recommended); signs of toxicity include nausea, vomiting and visual changes; many drug interactions
Zetia
Ezetimibe (PO)
Pharmacologic category: cholesterol absorption inhibitor
Common indication: dyslipidemia
Key side effects: diarrhea
Tricor, Trilipix
Fenofibrate (PO)
Pharmacologic category: fibric acid derivative
Common indication: dyslipidemia
Key side effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases
Lipitor
Atorvastatin (PO)
Pharmacologic category: HMG-CoA reductase inhibitor
Common indication: dyslipidemia, CAD, stroke
Key side effects: myopathy/rhabdomyolysis
US Boxed Warnings: fetal toxicity
Other Notes: avoid excessive grapefruit juice intake
Mevacor
Lovastatin (PO)
Pharmacologic category: HMG-CoA reductase inhibitor
Common indication: dyslipidemia, CAD, stroke
Key side effects: myopathy/rhabdomyolysis
US Boxed Warnings: fetal toxicity
Other Notes: avoid excessive grapefruit juice intake
Pravachol
Pravastatin (PO)
Pharmacologic category: HMG-CoA Reductase inhibitor
Common indication: dyslipidemia, CAD, stroke
Key side effects: myopathy/rhabdomyolysis
US Boxed Warnings: fetal toxicity
Other Notes: avoid excessive grapefruit juice intake
Crestor
Rosuvastatin (PO)
Pharmacologic category: HMG-CoA reductase inhibitor
Common indication: dyslipidemia, CAD, stroke
Key side effects: myopathy/rhabdomyolysis
US Boxed Warnings: fetal toxicity
Other Notes: avoid excessive grapefruit juice intake
Zocor
Simvastatin (PO)
Pharmacologic category: HMG-CoA reductase inhibitor
Common indication: dyslipidemia, CAD, stroke
Key side effects: myopathy/rhabdomyolysis
US Boxed Warnings: fetal toxicity
Other Notes: avoid excessive grapefruit juice intake
Lovaza
Omega-3 fatty acids (PO)
Pharmacologic category: omega-3 fatty acids
Common indication: dyslipidemia
Key side effects: diarrhea, nausea, dysgeusia, eructation
Niaspan
Niacin (extended release) (PO)
Pharmacologic category: water-soluble vitamin
Common indication: dyslipidemia
Key side effects: flushing, pruritus
Vytorin
Ezetimibe and simvastatin (PO)
Pharmacologic category: cholesterol absorption inhibitor and HMG-CoA reductase inhibitor
Common indication: dyslipidemia, CAD, stroke
Key side effects: diarrhea, myopathy/rhabdomyolysis
US Boxed Warnings: fetal toxicity
Other Notes: avoid excessive grapefruit juice intake
Lopid
gemfibrozil (PO)
Pharmacologic category: fibric acid derivative
Common indication: dyslipidemia
Key side effects: dyspepsia, myopathy/rhabdomyolysis, elevated hepatic transaminases